BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi M, An Q, Ainslie KEC, Haber M, Orenstein WA. A comparison of the test-negative and the traditional case-control study designs for estimation of influenza vaccine effectiveness under nonrandom vaccination. BMC Infect Dis 2017;17:757. [PMID: 29216845 DOI: 10.1186/s12879-017-2838-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Ainslie KEC, Shi M, Haber M, Orenstein WA. A Dynamic Model for Evaluation of the Bias of Influenza Vaccine Effectiveness Estimates From Observational Studies. Am J Epidemiol 2019;188:451-60. [PMID: 30329006 DOI: 10.1093/aje/kwy240] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
2 Vandenbroucke JP, Pearce N. Test-Negative Designs: Differences and Commonalities with Other Case-Control Studies with "Other Patient" Controls. Epidemiology 2019;30:838-44. [PMID: 31430265 DOI: 10.1097/EDE.0000000000001088] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 6.5] [Reference Citation Analysis]
3 Haber M, Lopman BA, Tate JE, Shi M, Parashar UD. Effect of propensity of seeking medical care on the bias of the estimated effectiveness of rotavirus vaccines from studies using a test-negative case-control design. Vaccine 2019;37:3229-33. [PMID: 31036459 DOI: 10.1016/j.vaccine.2019.04.065] [Reference Citation Analysis]
4 El-Heneidy A, Grimwood K, Lambert SB, Sarna M, Ware RS. Association between vaccination status, symptom identification and healthcare use: Implications for test negative design observational studies. Vaccine 2022:S0264-410X(22)00198-0. [PMID: 35216842 DOI: 10.1016/j.vaccine.2022.02.049] [Reference Citation Analysis]
5 Chon I, Saito R, Hibino A, Yagami R, Dapat C, Odagiri T, Kondo H, Sato I, Kimura S, Kawashima T, Kodo N, Masaki H, Asoh N, Tsuchihashi Y, Zaraket H, Shobugawa Y. Effectiveness of the quadrivalent inactivated influenza vaccine in Japan during the 2015-2016 season: A test-negative case-control study comparing the results by real time PCR, virus isolation. Vaccine X 2019;1:100011. [PMID: 31384733 DOI: 10.1016/j.jvacx.2019.100011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
6 Chua H, Feng S, Lewnard JA, Sullivan SG, Blyth CC, Lipsitch M, Cowling BJ. The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology. Epidemiology 2020;31:43-64. [PMID: 31609860 DOI: 10.1097/EDE.0000000000001116] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 19.0] [Reference Citation Analysis]
7 Ainslie KEC, Shi M, Haber M, Orenstein WA. On the bias of estimates of influenza vaccine effectiveness from test-negative studies. Vaccine 2017;35:7297-301. [PMID: 29146382 DOI: 10.1016/j.vaccine.2017.10.107] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
8 Hollingsworth R, El Guerche-Séblain C, Tsai T, Vasiliev Y, Lee S, Bright H, Barbosa P. Assessment of the benefits of seasonal influenza vaccination: Elements of a framework to interpret estimates of vaccine effectiveness and support robust decision-making and communication. Influenza Other Respir Viruses 2021;15:164-74. [PMID: 32885610 DOI: 10.1111/irv.12786] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Yeung KHT, Chan KCC, Chan PK, Lam DSY, Sham PCO, Yau YS, Chan WH, Chiu WK, Ng KL, Ng DKK, Chan IMC, Nelson EAS. Influenza vaccine effectiveness in hospitalised Hong Kong children: Feasibility of estimates from routine surveillance data. Vaccine 2018;36:3477-85. [DOI: 10.1016/j.vaccine.2018.04.081] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
10 Lewnard JA, Cobey S. Immune History and Influenza Vaccine Effectiveness. Vaccines (Basel) 2018;6:E28. [PMID: 29883414 DOI: 10.3390/vaccines6020028] [Cited by in Crossref: 71] [Cited by in F6Publishing: 77] [Article Influence: 17.8] [Reference Citation Analysis]
11 Ainslie KEC, Haber M, Orenstein WA. Bias of influenza vaccine effectiveness estimates from test-negative studies conducted during an influenza pandemic. Vaccine 2019;37:1987-93. [PMID: 30833155 DOI: 10.1016/j.vaccine.2019.02.036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
12 Brent SE, Pullenayegum E, Russell ML, Loeb M. Effect of seasonal influenza vaccination on influenza symptom severity among children in Hutterite communities: Follow-up study of a randomized trial. Influenza Other Respir Viruses 2020;14:28-36. [PMID: 31702876 DOI: 10.1111/irv.12689] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
13 Segaloff HE, Cheng B, Miller AV, Petrie JG, Malosh RE, Cheng C, Lauring AS, Lamerato LE, Ferdinands JM, Monto AS, Martin ET. Influenza Vaccine Effectiveness in the Inpatient Setting: Evaluation of Potential Bias in the Test-Negative Design by Use of Alternate Control Groups. Am J Epidemiol 2020;189:250-60. [PMID: 31673696 DOI: 10.1093/aje/kwz248] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Haber M, Lopman BA, Tate JE, Shi M, Parashar UD. A comparison of the test-negative and traditional case-control study designs with respect to the bias of estimates of rotavirus vaccine effectiveness. Vaccine 2018;36:5071-6. [PMID: 29980389 DOI: 10.1016/j.vaccine.2018.06.072] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
15 Kochhar S, Excler JL, Bok K, Gurwith M, McNeil MM, Seligman SJ, Khuri-Bulos N, Klug B, Laderoute M, Robertson JS, Singh V, Chen RT; Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG). Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccines. Vaccine 2019;37:5796-802. [PMID: 30497831 DOI: 10.1016/j.vaccine.2018.08.085] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
16 Tanner AR, Dorey RB, Brendish NJ, Clark TW. Influenza vaccination: protecting the most vulnerable. Eur Respir Rev 2021;30:200258. [PMID: 33650528 DOI: 10.1183/16000617.0258-2020] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 de Lusignan S, Lopez Bernal J, Byford R, Amirthalingam G, Ferreira F, Akinyemi O, Andrews N, Campbell H, Dabrera G, Deeks A, Elliot AJ, Krajenbrink E, Liyanage H, McGagh D, Okusi C, Parimalanathan V, Ramsay M, Smith G, Tripathy M, Williams J, Victor W, Zambon M, Howsam G, Nicholson BD, Tzortziou Brown V, Butler CC, Joy M, Hobbs FDR. Influenza and Respiratory Virus Surveillance, Vaccine Uptake, and Effectiveness at a Time of Cocirculating COVID-19: Protocol for the English Primary Care Sentinel System for 2020-2021. JMIR Public Health Surveill 2021;7:e24341. [PMID: 33605892 DOI: 10.2196/24341] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
18 Ciocănea-Teodorescu I, Nason M, Sjölander A, Gabriel EE. Adjustment for Disease Severity in the Test-Negative Study Design. Am J Epidemiol 2021;190:1882-9. [PMID: 33728441 DOI: 10.1093/aje/kwab066] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Schnitzer ME, Harel D, Ho V, Koushik A, Merckx J. Identifiability and Estimation Under the Test-negative Design With Population Controls With the Goal of Identifying Risk and Preventive Factors for SARS-CoV-2 Infection. Epidemiology 2021;32:690-7. [PMID: 34183531 DOI: 10.1097/EDE.0000000000001385] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Ainslie KEC, Haber M, Orenstein WA. Challenges in estimating influenza vaccine effectiveness. Expert Rev Vaccines 2019;18:615-28. [PMID: 31116070 DOI: 10.1080/14760584.2019.1622419] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]